Home / Business / Business News / Bristol-Myers gets 'potentially revolutionary medicine' in MyoKardia deal, CEO says

Bristol-Myers gets 'potentially revolutionary medicine' in MyoKardia deal, CEO says

October 06, 2020 Business, Business News

"MyoKardia is an important company because they developed a really interesting approach to the treatment of cardiovascular disease," Bristol-Myers Squibb CEO Giovanni Caforio said.

from Business News https://ift.tt/3jFNraY
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )